Opendata, web and dolomites

PREDICT SIGNED

Big Data EEG-Analysis for Advanced Personalised Medicine in Depression

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PREDICT project word cloud

Explore the words cloud of the PREDICT project. It provides you a very rough idea of what is the project "PREDICT" about.

elminda    therapies    hinders    reduces    heavy    eluded    treat    medicine       ownership    patient    biomarkers    rarely    prevents    quantifying    disorder    tms    temperature    mdd    doctors    life    98    substantiation    savings    ranges    modern    brain    tool    33    metrics    compare    body    functions    suspected    remission    amelioration    suffer    fat    percentage    gdp    individual    event    prescribed    trial    diagnose    time    quality    normal    diagnosis    brains    treatments    error    symptoms    right    accounting    measuring    treatment    equivalent    health    antidepressants    responsiveness    patients    mental    countless    personalised    healthcare    predict    predicts    electroencephalogram    weight       unable    slows    organ    million    equal    total    invasive    day    ailments    disorders    people    rates    cholesterol    measured    delays    psa    accurately    truly    depressive    population    receiving    easily    determines    costly    improves    52    validated    dramatically   

Project "PREDICT" data sheet

The following table provides information about the project.

Coordinator
ELMINDA LTD 

Organization address
address: Shenkar 1, WeWork Building
city: HERZLIYA
postcode: 4673314
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 2˙798˙450 €
 EC max contribution 1˙958˙915 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2021-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ELMINDA LTD IL (HERZLIYA) coordinator 1˙958˙915.00

Map

 Project objective

Modern medicine has given us countless methods of understanding, measuring and managing such metrics of our health as temperature, weight, body fat percentage, cholesterol, PSA values, etc. A patient’s measured values are easily compared against well-established normal ranges. And yet a simple, non-invasive method for measuring and quantifying the health of our brains has eluded us. Being unable to accurately measure and compare how a brain functions hinders doctors’ ability to diagnose and treat suspected ailments. It also slows the substantiation of new therapies. And, just as importantly, it prevents each of us from truly understanding and taking ownership of the health of our body’s most important organ. Major Depressive Disorder (MDD) has been identified as the leading and most costly mental disorder, accounting for 33% of the total cost of brain disorders, and equal to 1% of the GDP. Each year, about 7% of the population suffer from MDD in Europe, equivalent to 52.98 million people. The current methods of treatment are prescribed through trial and error with patients rarely receiving the ‘right’ treatment from day one. This reduces response rates and delays remission, which has a heavy impact on the individual’s quality of life. elminda has developed the “PREDICT” tool which predicts responsiveness to antidepressants and TMS treatment, and thus dramatically reduces time from diagnosis to amelioration of symptoms for MDD patients. PREDICT determines personalised treatments for MDD patients based on validated electroencephalogram and event-related potential brain-related biomarkers. The tool predicts responsiveness to antidepressants and TMS treatment, and thus dramatically reduces time from diagnosis to amelioration of symptoms. This improves response rates, quality of life and results in significant savings for the healthcare systems.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREDICT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREDICT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

COPI (2020)

Carbon Offset Plug-in

Read More  

ECOBIOMASS (2019)

Achieving unique wines through an efficient production process

Read More  

ALR4000 (2019)

Automated LCD Recycling series 4000

Read More